BLISSERIGO

Film-coated tablet, 20 mg
RxActive license

Active substance (INN)

tadalafil

Pharmaceutical form

Pharmaceutical formFilm-coated tablet
Strength20 mg
PackagingUkupno 2 film tablete u blisteru (1x2) u kartonskoj kutiji
ManufacturerZaklady Farmaceutyczne Polpharma S.A., Poland
Therapeutic groupGenito-urinary system and sex hormones (G04BE08)
Marketing authorization holder"GOODWILL PHARMA" DRUŠTVO SA OGRANIČENOM ODGOVORNOŠĆU PODGORICA
Authorization dateOctober 5, 2023

Analogs in Montenegro

10

Other medicines with the same active substance

BILIVERx
Film-coated tablet, 5mgPharmaswiss d.o.o.
BILIVERx
Film-coated tablet, 10mgPharmaswiss d.o.o.
BILIVERx
Film-coated tablet, 20mgPharmaswiss d.o.o.
BLISSERIGORx
Film-coated tablet, 5 mgZaklady Farmaceutyczne Polpharma S.A.
CAVEDARx
Film-coated tablet, 2.5mgHemofarm a.d.
CAVEDARx
Film-coated tablet, 5mgHemofarm a.d.
CAVEDARx
Film-coated tablet, 10mgHemofarm a.d.
CAVEDARx
Film-coated tablet, 20mgHemofarm a.d.
TADALAFIL MYLANRx
Film-coated tablet, 20mgMylan Hungary Kft.
TADALAFIL MYLANRx
Film-coated tablet, 10mgMylan Hungary Kft.
Source: CInMED register